Ad
related to: congenital adrenal hyperplasia in boys treatment
Search results
Results from the WOW.Com Content Network
In the United States, congenital adrenal hyperplasia in its classic form is particularly common in Native Americans and Yupik Inuit (incidence 1 ⁄ 280). Among American Caucasians, the incidence of the classic form is about 1 ⁄ 15,000). [24] Continued treatment and wellness are enhanced by education and follow up. [35]
The outcomes and prognosis for CAH (Congenital Adrenal Hyperplasia) can vary depending on several factors, such as the specific type of CAH, its severity, early detection, and proper management. With appropriate medical care and ongoing treatment, individuals with CAH can lead healthy lives.
Late onset congenital adrenal hyperplasia (LOCAH), also known as nonclassic congenital adrenal hyperplasia (NCCAH or NCAH), is a milder form of congenital adrenal hyperplasia (CAH), [1] a group of autosomal recessive disorders characterized by impaired cortisol synthesis that leads to variable degrees of postnatal androgen excess.
[14] [15] [16] Preimplantation genetic diagnosis for those receiving in vitro fertilization can detect variations such as congenital adrenal hyperplasia (CAH) and androgen insensitivity syndrome (AIS). [17] 21-hydroxylase deficiency, also known as congenital adrenal hyperplasia 1, can be treated prenatally using dexamethasone to prevent ...
Congenital adrenal hyperplasia due to 17α-hydroxylase deficiency is an uncommon form of congenital adrenal hyperplasia (CAH) resulting from a mutation in the gene CYP17A1, which produces the enzyme 17α-hydroxylase. [1] [2] It causes decreased synthesis of cortisol and sex hormones, with resulting increase in mineralocorticoid production.
Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency is an uncommon form of congenital adrenal hyperplasia (CAH) resulting from a mutation in the gene for one of the key enzymes in cortisol synthesis by the adrenal gland, 3β-hydroxysteroid dehydrogenase (3β-HSD) type II ().
Congenital adrenal hyperplasia is a group of autosomal recessive disorders characterized by impaired cortisol synthesis. [23] [24] It results from the deficiency of one of the five enzymes required for the synthesis of cortisol in the adrenal cortex. [25]
Genetic variants in the CYP21A2 gene cause a disturbance in the development of the enzyme, leading to congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Gene conversion events involving the functional gene and the pseudogene account for many cases of steroid 21-hydroxylase deficiency. [64] CAH is an autosomal recessive ...
Ad
related to: congenital adrenal hyperplasia in boys treatment